Phase 2 Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have given written consent to participate in the study
- People who have been diagnosed with advanced cancer confirmed by laboratory tissue testing — specifically colorectal cancer, head and neck squamous cell cancer, non-small cell lung cancer, or gastric cancer (including cancer at the junction of the stomach and oesophagus)
- People who have already received at least one round of chemotherapy or similar drug treatment for cancer that has spread or cannot be surgically removed
- People who are 18 years of age or older
- People who are willing to follow the study procedures throughout the trial
Who may not be able to join:
- People who have a history of, or currently have, any significant health conditions that the trial doctor considers medically important (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +46708555182
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Frequency of treatment-emergent adverse events (TEAEs); Incidence of severe treatment-emergent adverse events (TEAEs) per Common Terminology for Adverse Events (CTCAE) V5.0 grading; Incidence of treatment-emergent adverse events (TEAEs) related to treatment, as assessed by the Investigator; Frequency of serious adverse events (SAEs); Incidence of serious adverse events (SAEs) per the seriousness criteria defined in the protocol.; Incidence of serious adverse events (SAEs) related to treatment, as assessed by the Investigator; Incidence of out of range clinical laboratory tests (as defined by t...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.